alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FINANCIAL
STATEMETNS FOR THE PERIOD ENDED SEPTEMBER 30, 1998 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                          22,655
<SECURITIES>                                         0
<RECEIVABLES>                                    5,133
<ALLOWANCES>                                       479
<INVENTORY>                                          0
<CURRENT-ASSETS>                                30,722
<PP&E>                                           3,585
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  34,575
<CURRENT-LIABILITIES>                            4,449
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           139
<OTHER-SE>                                      29,937
<TOTAL-LIABILITY-AND-EQUITY>                    34,575
<SALES>                                         11,661
<TOTAL-REVENUES>                                20,494
<CGS>                                            1,843
<TOTAL-COSTS>                                    5,220
<OTHER-EXPENSES>                                24,512
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (9,238)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (8,016)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (8,016)
<EPS-PRIMARY>                                   (0.60)
<EPS-DILUTED>                                   (0.60)
        

</TABLE>
[No. 37784-1-I.

Division One.

May 27, 1997.]

#### Marty J. Stover, *Appellant,*v. Seattle Enterprise, Inc., et al., *Respondents.*

Appeal from a judgment of the Superior Court for King County, No. 93-2-17695-3, Jim Bates, J., entered November 3, 1995. *Affirmed*by unpublished opinion per Ellington, J., concurred in by Kennedy, A.C.J., and Grosse, J.
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 94 Introduced in House (IH)]

109th CONGRESS
  1st Session
H. RES. 94

 Providing amounts for the expenses of the Committee on Agriculture in 
                    the One Hundred Ninth Congress.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 15, 2005

Mr. Goodlatte submitted the following resolution; which was referred to 
                 the Committee on House Administration

_______________________________________________________________________

                               RESOLUTION

 
 Providing amounts for the expenses of the Committee on Agriculture in 
                    the One Hundred Ninth Congress.

    Resolved, 

SECTION 1. AMOUNTS FOR COMMITTEE EXPENSES.

    For the expenses of the Committee on Agriculture (hereafter in this 
resolution referred to as the ``Committee''), including the expenses of 
all staff salaries, there shall be paid, out of the applicable accounts 
of the House of Representatives for committee salaries and expenses, 
not more than $11,562,481 for the One Hundred Ninth Congress.

SEC. 2. SESSION LIMITATIONS.

    Of the amount specified in section 1--
            (1) not more than $5,595,604 shall be available for 
        expenses incurred during the period beginning at noon on 
        January 3, 2005, and ending immediately before noon on January 
        3, 2006; and
            (2) not more than $5,966,877 shall be available for 
        expenses incurred during the period beginning at noon on 
        January 3, 2006, and ending immediately before noon on January 
        3, 2007.

SEC. 3. VOUCHERS.

    Payments under this resolution shall be made on vouchers authorized 
by the Committee, signed by the Chairman of the Committee, and approved 
in the manner directed by the Committee on House Administration.

SEC. 4. REGULATIONS.

    Amounts made available under this resolution shall be expended in 
accordance with regulations prescribed by the Committee on House 
Administration.
                                 <all>
```
Editorial Note on Part 173
Editorial Note: Nomenclature changes to part 173 appear at 61 FR 14482, Apr. 2, 1996; 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; and 81 FR 49896, July 29, 2016.

§ 173.110 Amyloglucosidase derived from *Rhizopus niveus.* Amyloglucosidase enzyme product, consisting of enzyme derived from *Rhizopus niveus,* and diatomaceous silica as a carrier, may be safely used in food in accordance with the following conditions: ( a ) *Rhizopus niveus* is classified as follows: Class, Phycomycetes; order, Mucorales; family, Mucoraceae; genus, *Rhizopus;* species, *niveus.*
( b ) The strain of *Rhizopus niveus* is nonpathogenic and nontoxic in man or other animals.
( c ) The enzyme is produced by a process which completely removes the organism *Rhizopus niveus* from the amyloglucosidase.
( d ) The additive is used or intended for use for degrading gelatinized starch into constituent sugars, in the production of distilled spirits and vinegar.
( e ) The additive is used at a level not to exceed 0.1 percent by weight of the gelatinized starch.
Editorial Note on Part 17
Editorial Note: Nomenclature changes to part 17 appear at 68 FR 24879, May 9, 2003, and at 88 FR 45065, July 14, 2023.

§ 17.1 Scope. This part sets forth practices and procedures for hearings concerning the administrative imposition of civil money penalties by FDA. Listed below are the statutory provisions that authorize civil money penalties that are governed by these procedures. ( a ) Section 303(b)(2) and (b)(3) of the Federal Food, Drug, and Cosmetic Act (the act) authorizing civil money penalties for certain violations of the act that relate to prescription drug marketing practices.
( b ) Section 303(f)(1) of the act authorizing civil money penalties for certain violations of the act that relate to medical devices and section 303(f)(2) of the act authorizing civil money penalties for certain violations of the act that relate to pesticide residues.
( c ) Section 303(f)(3) of the act authorizing civil money penalties for certain violations relating to the submission of certifications and/or clinical trial information to the clinical trial data bank and section 303(f)(4) of the act authorizing civil money penalties for certain violations of the act relating to postmarket studies, clinical trial requirements, and risk evaluation and mitigation strategies for drugs.
( d ) Section 303(g)(1) of the act authorizing civil money penalties for certain violations of the act that relate to dissemination of direct-to-consumer advertisements for approved drugs or biological products.
( e ) Section 307 of the act authorizing civil money penalties for certain actions in connection with an abbreviated new drug application or certain actions in connection with a person or individual debarred under section 306 of the act.
( f ) Section 539(b)(1) of the act authorizing civil money penalties for certain violations of the act that relate to electronic products.
( g ) Section 351(d)(2) of the Public Health Service Act (the PHS Act) authorizing civil money penalties for violations of biologic recall orders.
( h ) Section 354(h)(3) of the PHS Act, as amended by the Mammography Quality Standards Act of 1992 and the Mammography Quality Standards Act of 1998, authorizing civil money penalties for failure to obtain a certificate and failure to comply with established standards, among other things.
( i ) Section 2128(b)(1) of the PHS Act authorizing civil money penalties for intentionally destroying, altering, falsifying, or concealing any record or report required to be prepared, maintained, or submitted by vaccine manufacturers under section 2128 of the PHS Act.
( j ) Section 303(f) of the act authorizing civil money penalties for any person who violates a requirement of the Family Smoking Prevention and Tobacco Control Act which relates to tobacco products.
[60 FR 38626, July 27, 1995, as amended at 69 FR 43301, July 20, 2004; 73 FR 66752, Nov. 12, 2008; 75 FR 73953, Nov. 30, 2010]
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM BODDIE-NOELL
PROPERTIES, INC. FINANCIAL STATEMENTS AS OF AND FOR THE NINE MONTHS ENDED
SEPTEMBER 30, 1997, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                                        <C>
<PERIOD-TYPE>                              9-MOS   
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JUN-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                       1,406,892
<SECURITIES>                                         0
<RECEIVABLES>                                   34,734
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             2,036,814
<PP&E>                                     110,345,762
<DEPRECIATION>                             (13,383,980)
<TOTAL-ASSETS>                             104,205,598
<CURRENT-LIABILITIES>                        1,286,610
<BONDS>                                     78,396,552
<COMMON>                                    35,194,270
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                 (11,243,970)
<TOTAL-LIABILITY-AND-EQUITY>               104,205,598
<SALES>                                              0
<TOTAL-REVENUES>                            11,609,255
<CGS>                                                0
<TOTAL-COSTS>                                4,459,329
<OTHER-EXPENSES>                             1,173,200
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           4,684,256
<INCOME-PRETAX>                              1,292,470
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          1,292,470
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,292,470
<EPS-PRIMARY>                                     0.42
<EPS-DILUTED>                                     0.42
        



</TABLE>
§ 1500.14 Definitions. As used in this subpart: ( a ) *Action Official (AO)* is the EPA official who authors the Agency Decision to the Affected Entity regarding a pre-award or post-award matter.
( b ) *Affected Entity* is an entity that applies for and/or receives Federal financial assistance from EPA including but not limited to: State and local governments, Indian Tribes, Intertribal Consortia, Institutions of Higher Education, Hospitals, and other Non-profit Organizations, and Individuals.
( c ) *Agency Decision* is the agency's initial pre-award or post-award assistance agreement determination that may be disputed in accordance with this subpart. The Agency Decision is sent by the Action Official (AO) to the Affected Entity electronically and informs them of their dispute rights and identifies the Dispute Decision Official (DDO). An Agency Decision based on audit findings serves as EPA's *Management decision* as defined in 2 CFR part 200.1.
( d ) *Dispute* is a disagreement by an Affected Entity with a specific Agency Decision submitted to the DDO in accordance with this subpart.
( e ) *Dispute Decision Official (DDO)* is the designated agency official responsible for issuing a decision resolving a Dispute. ( 1 ) The DDO for a Headquarters Dispute is the Director of the Grants and Interagency Agreement Management Division in the Office of Grants and Debarment or designee. To provide for a fair and impartial review, the AO for the challenged Agency Decision may not serve as the Headquarters DDO.
( 2 ) The DDO for a Regional Assistance Agreement Dispute is the Regional Administrator or the official designated by the Regional Administrator to issue the written decision resolving the Dispute. To provide for a fair and impartial review, the AO for the challenged Agency Decision may not serve as the Regional DDO.
[79 FR 76050, Dec. 19, 2014. Redesignated at 85 FR 61573, Sept. 30, 2020; 85 FR 61574, Sept. 30, 2020, as amended at 87 FR 30397, May 19, 2022]
#### § 1316.32 Notice of proceeding; time and place.

Appropriate notice designating the time and place for the hearing shall be given to the person. Upon request, timely and properly made, by the person to whom notice has been given, the time or place of the hearing, or both, may be changed if the request states reasonable grounds for such change. Such request shall be addressed to the Special Agent in Charge who issued the notice.

[36 FR 7820, Apr. 24, 1971. Redesignated at 38 FR 26609, Sept. 24, 1973, and amended at 47 FR 41735, Sept. 22, 1982]
#### § 1302.04 Location and size of symbol on label and labeling.

The symbol shall be prominently located on the label or the labeling of the commercial container and/or the panel of the commercial container normally displayed to dispensers of any controlled substance. The symbol on labels shall be clear and large enough to afford easy identification of the schedule of the controlled substance upon inspection without removal from the dispenser's shelf. The symbol on all other labeling shall be clear and large enough to afford prompt identification of the controlled substance upon inspection of the labeling.

[62 FR 13958, Mar. 24, 1997]
```

[Federal Register: January 18, 2011 (Volume 76, Number 11)]
[Notices]               
[Page 2889]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18ja11-37]                         

=======================================================================
-----------------------------------------------------------------------

CONSUMER PRODUCT SAFETY COMMISSION

 
Sunshine Act Meeting Notice

TIME AND DATE: Wednesday, January 19, 2011; 10 a.m.-11 a.m.

PLACE: Hearing Room 420, Bethesda Towers, 4330 East West Highway, 
Bethesda, Maryland.

STATUS: Closed to the public.

Matter To Be Considered

Compliance Status Report

    The Commission staff will brief the Commission on the status of 
compliance matters.
    For a recorded message containing the latest agenda information, 
call (301) 504-7948.

CONTACT PERSON FOR MORE INFORMATION: Todd A. Stevenson, Office of the 
Secretary, U.S. Consumer Product Safety Commission, 4330 East West 
Highway, Bethesda, MD 20814, (301) 504-7923.

    Dated: January 11, 2011.
Todd A Stevenson,
Secretary.
[FR Doc. 2011-1031 Filed 1-13-11; 4:15 pm]
BILLING CODE 6355-01-P
```
#### § 1400.332 What methods must I use to pass requirements down to participants at lower tiers with whom I intend to do business?

You as a participant must include a term or condition in lower-tier transactions requiring lower-tier participants to comply with subpart C of the OMB guidance in 2 CFR part 180.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   3-MOS
<FISCAL-YEAR-END>                          MAR-31-1997             MAR-31-1996
<PERIOD-START>                             OCT-01-1997             OCT-01-1996
<PERIOD-END>                               DEC-31-1997             DEC-31-1996
<CASH>                                             411                      68
<SECURITIES>                                         0                       0
<RECEIVABLES>                                        0                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                     0                       0
<PP&E>                                               0                       0
<DEPRECIATION>                                       0                       0
<TOTAL-ASSETS>                                     411                      68
<CURRENT-LIABILITIES>                            7,350                   6,600
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                        15,000                  15,000
<OTHER-SE>                                    (21,939)                (21,532)
<TOTAL-LIABILITY-AND-EQUITY>                       411                      68
<SALES>                                              0                       0
<TOTAL-REVENUES>                                     0                       0
<CGS>                                                0                       0
<TOTAL-COSTS>                                       44                      29
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                                     44                      29
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                        44                      29
<EPS-PRIMARY>                                        0                       0
<EPS-DILUTED>                                        0                       0
        

</TABLE>
§ 1130.100 Purpose of PROP Article I. PROP Article I specifies in whom and under what conditions title to property vests under the award. It thereby implements OMB guidance for grants and cooperative agreements: ( a ) Pertaining to vesting of title to property, in 2 CFR 200.311(a), 200.312(a), 200.313(a), 200.314(a), and 200.315(a).
( b ) Pertaining to the property trust relationship in 2 CFR 200.316.
# LI2018252EN.01000101.xml

| 8.10.2018 | EN | Official Journal of the European Union | LI 252/1 |
| --- | --- | --- | --- |

8.10.2018

EN

Official Journal of the European Union

LI 252/1

---

COMMISSION IMPLEMENTING REGULATION (EU) 2018/1494

of 8 October 2018

amending for the 291st time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da'esh) and Al-Qaida organisations

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Council Regulation (EC) No 881/2002 of 27 May 2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the ISIL (Da'esh) and Al-Qaida organisations (1), and in particular Article 7(1)(a) and Article 7a(1) thereof,

Whereas:

| (1) | Annex I to Regulation (EC) No 881/2002 lists the persons, groups and entities covered by the freezing of funds and economic resources under that Regulation. |
| --- | --- |

(1)

Annex I to Regulation (EC) No 881/2002 lists the persons, groups and entities covered by the freezing of funds and economic resources under that Regulation.

| (2) | On 4 October 2018, the Sanctions Committee of the United Nations Security Council decided to add one entry to the list of persons, groups and entities to whom the freezing of funds and economic resources should apply. Annex I to Regulation (EC) No 881/2002 should therefore be amended accordingly. |
| --- | --- |

(2)

On 4 October 2018, the Sanctions Committee of the United Nations Security Council decided to add one entry to the list of persons, groups and entities to whom the freezing of funds and economic resources should apply. Annex I to Regulation (EC) No 881/2002 should therefore be amended accordingly.

| (3) | In order to ensure that the measures provided for in this Regulation are effective it should enter into force immediately, |
| --- | --- |

(3)

In order to ensure that the measures provided for in this Regulation are effective it should enter into force immediately,

HAS ADOPTED THIS REGULATION:

Article 1

Annex I to Regulation (EC) No 881/2002 is amended in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the day of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 8 October 2018.

For the Commission,

On behalf of the President,

Head of the Service for Foreign Policy Instruments

---

(1)  
  OJ L 139, 29.5.2002, p. 9.

1

---

ANNEX

In Annex I to Regulation (EC) No 881/2002 the following entry is added under the heading ‘Legal persons, groups and entities’:

‘Jama'a Nusrat ul-Islam wa al-Muslimin (JNIM). Date of designation referred to in Article 7d(2)(i): 4.10.2018.’

---
Editorial Note on Part 112
Editorial Note: Nomenclature changes to part 112 appear at 81 FR 49896, July 29, 2016.

§ 112.127 What requirements apply regarding domesticated animals in and around a fully-enclosed building? ( a ) You must take reasonable precautions to prevent contamination of covered produce, food contact surfaces, and food-packing materials in fully-enclosed buildings with known or reasonably foreseeable hazards from domesticated animals by: ( 1 ) Excluding domesticated animals from fully-enclosed buildings where covered produce, food contact surfaces, or food-packing material is exposed; or
( 2 ) Separating domesticated animals in a fully enclosed building from an area where a covered activity is conducted on covered produce by location, time, or partition.
( b ) Guard or guide dogs may be allowed in some areas of a fully enclosed building if the presence of the dogs is unlikely to result in contamination of produce, food contact surfaces, or food-packing materials.